Flamel Technologies (FLML) Tops Q4 EPS by 5c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- Wall Street indexes slip as oil prices rise, retail results awaited
- Trump threatens to bomb Oman over Iran stance
- Why this Wall Street strategist says the "trade is long gold"
- U.S. EV market shows signs of bottoming out: Bernstein
- Micron rises as White House presses Apple to avoid Chinese memory chips
- Wall Street indexes slip as oil prices rise, retail results awaited
- Oil settles up over $2 as Iran war stalemate stokes supply concerns
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Micron rises as White House presses Apple to avoid Chinese memory chips
- Trump threatens to bomb Oman over Iran stance
Flamel Technologies Announces Fourth Quarter and Full Year Results of Fiscal Year 2014
March 19, 2015 8:01 AM EDTLYON, FRANCE -- (Marketwired) -- 03/19/15 -- Flamel Technologies (NASDAQ: FLML) today announced its financial results for the fourth quarter of fiscal year 2014. Highlights from the quarter include:
Flamel announced positive results of a second clinical trial with the company's proprietary Micropump Sodium Oxybate, reconfirming potential elimination of the 'middle-of-the-night' dose that is required with the currently available drug for treating narcolepsy Flamel's intellectual property, including patents on its drug delivery platform technologies, clinical data sets and other intangible assets related to its pipeline of proprietary products in development, has been relocated to the... More